An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...

Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug - Pharmacists who ...

For weight loss, SGLT2 inhibitors are ranked as intermediate in efficacy. They rank higher than Glumetza (metformin), but lower than newer injectable drugs, such as Mounjaro (tirzepatide ... the ...

Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Medicine Weight ...

Drugs like Ozempic, Mounjaro and Saxenda have swept the globe since emerging on the market late last decade, and an estimated 20,000 Australians currently use the drugs for weight loss.

As of January 2025, Ozempic's weekly prescriptions were reported at 576,790, while Mounjaro (tirzepatide ... agonist that has shown competitive weight loss percentages in early trials.

Oprah Winfrey is sharing new details on her weight loss in recent years ... have complications from being overweight. Ozempic and Mounjaro are approved to treat Type 2 diabetes.

At an in-person appointment, a doctor will assess your current health, weight-loss ... in limited dose ranges but cost less. To learn more about GLP-1 drugs, read our articles on Mounjaro, Wegovy ...

Whether you’ve been prescribed Mounjaro (tirzepatide) for type 2 diabetes, weight loss, or both, you’re likely wondering what to eat (and not to eat) while taking the medication. After all ...